The 18th EORTC-NCI-AACR Symposium on "Molecular Targets and Cancer Therapeutics" was held from Tuesday, November 7 to Friday, November 10, 2006 at the Prague Congress Centre in Prague, Czech Republic. This symposium, hosted by EORTC, NCI and AACR, attracted 2,200 academics, scientists, and representatives from the pharmaceutical industry to discuss innovations in drug development, target selection, and the impact of new discoveries in molecular biology.
During the previous few years, numerous innovative agents had been discovered as a result of tremendous developments in the understanding of the molecular basis of cancer. Further clinical progress in cancer treatment will be accomplished mainly through the conduct of translational research projects, efficient new drug development, and the execution of large, prospective, randomised, multicentre cancer clinical trials. This will require a joint and global approach, and early and optimal exchange of information.
For additional information about the 2006 Symposium, please visit the Federation of European Cancer Societies website or contact:
EORTC-NCI-AACR Conference secretariat
Federation of European Cancer Societies
Avenue E. Mounier 83
B-1200 Brussels, Belgium
Phone: +32 (0)2 775 02 01
Fax: +32 (0)2 775 02 00
E-mail: ENA2006@fecs.be